Neurocrine Biosciences Inc (NBIX)

NASDAQ · Biotechnology

154.11
-0.38 (-0.25%)
Updated Aug 18, 2:38 PM ET
AI Rating
Hold
Overall Score
42
Trend
48
Momentum
23
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Neurocrine Biosciences Inc is trading at $154.11, down 0.25% on the session. The 50 day average sits at $167.95 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 35.3, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $148.78 with resistance near $165.46, so that band frames the current range. Average daily movement is roughly $5.73, or about 3.7% of the share price, which is what any stop placement has to allow for. The overall health score of 42 out of 100 combines a trend score of 48, momentum of 23 and a risk score of 58.

Technical indicators

RSI (14)
35.3
weak
MACD
-4.114
bearish crossover
SMA 20
168.55
SMA 50
167.95
SMA 200
--
unknown
ATR (14)
5.73
avg daily range
Support
148.78
Resistance
165.46
Volume vs 20d
0.90x
below average
Volatility
51.5%
annualised
1 month
-10.98%
3 months
-3.98%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.